MXPA04010091A - Composiciones y metodos para el diagnostico y tratamiento de tumores. - Google Patents

Composiciones y metodos para el diagnostico y tratamiento de tumores.

Info

Publication number
MXPA04010091A
MXPA04010091A MXPA04010091A MXPA04010091A MXPA04010091A MX PA04010091 A MXPA04010091 A MX PA04010091A MX PA04010091 A MXPA04010091 A MX PA04010091A MX PA04010091 A MXPA04010091 A MX PA04010091A MX PA04010091 A MXPA04010091 A MX PA04010091A
Authority
MX
Mexico
Prior art keywords
antibody
tat
polypeptide
amino acid
seq
Prior art date
Application number
MXPA04010091A
Other languages
English (en)
Spanish (es)
Inventor
I Wood William
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MXPA04010091A publication Critical patent/MXPA04010091A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA04010091A 2002-04-17 2002-04-17 Composiciones y metodos para el diagnostico y tratamiento de tumores. MXPA04010091A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/012206 WO2003088898A2 (en) 2002-04-17 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor

Publications (1)

Publication Number Publication Date
MXPA04010091A true MXPA04010091A (es) 2004-12-13

Family

ID=29247990

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04010091A MXPA04010091A (es) 2002-04-17 2002-04-17 Composiciones y metodos para el diagnostico y tratamiento de tumores.

Country Status (7)

Country Link
EP (1) EP1494709A4 (de)
JP (1) JP2005523311A (de)
KR (1) KR20040111525A (de)
AU (1) AU2002254651A1 (de)
CA (1) CA2481085A1 (de)
MX (1) MXPA04010091A (de)
WO (1) WO2003088898A2 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082540A1 (en) * 1997-09-17 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6291663B1 (en) * 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
AU2001233262A1 (en) * 2000-02-03 2001-08-14 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001259271A1 (en) * 2000-04-28 2001-11-12 Millennium Pharmaceuticals, Inc. 14094, a novel human trypsin family member and uses thereof

Also Published As

Publication number Publication date
KR20040111525A (ko) 2004-12-31
EP1494709A4 (de) 2006-06-28
JP2005523311A (ja) 2005-08-04
AU2002254651A1 (en) 2003-11-03
EP1494709A2 (de) 2005-01-12
WO2003088898A2 (en) 2003-10-30
WO2003088898A3 (en) 2004-09-16
CA2481085A1 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
AU2003249014B2 (en) Compositions and methods for the diagnosis and treatment of tumor
US7514538B2 (en) Compositions and methods for the diagnosis and treatment of tumor
US20130210116A1 (en) Composition and methods for the diagnosis and treatment of tumor
MXPA05001933A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
MXPA04010092A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
AU2001270118A1 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA04012243A (es) Composiciones y metodos para l diagnostico y tratamiento de tumores.
US6914130B2 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002016581A2 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2001286785B2 (en) Compositions and methods for the diagnosis and treatment of tumor
US8097700B2 (en) TAT294 polypeptides
AU2001286785A1 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2006230703A1 (en) Compositions and methods for the diagnosis and treatment of tumor
US20020161199A1 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2001284906A1 (en) Compositions and methods for the diagnosis and treatment of tumor
US20070031901A1 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA04010091A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
MXPA04005945A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
WO2003090600A2 (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200408159B (en) Compositions and methods for the diagnosis and treatment of tumor

Legal Events

Date Code Title Description
FG Grant or registration